Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients

被引：0
作者：
Pardha Devaki
David Jencks
Brittany E. Yee
Mindie H. Nguyen
机构：
[1] Cleveland Clinic,Digestive Disease Institute
[2] Veterans’ Administration Health Care System,Department of Medicine
[3] University of California,School of Medicine
[4] Stanford University Medical Center,Division of Gastroenterology and Hepatology
来源：
Hepatology International | 2015年 / 9卷
关键词：
Hepatitis C; Genotype 5; Sustained virologic response; Peginterferon and ribavirin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 437
页数：6
相关论文
共 50 条
  • [1] Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients
    Devaki, Pardha
    Jencks, David
    Yee, Brittany E.
    Nguyen, Mindie H.
    HEPATOLOGY INTERNATIONAL, 2015, 9 (03) : 431 - 437
  • [2] Pegylated versus standard interferon plus ribavirin in chronic hepatitis C genotype 4: A systematic review and meta-analysis
    Aljumah, Abdulrahman A.
    Murad, Mohammad Hassan
    HEPATOLOGY RESEARCH, 2013, 43 (12) : 1255 - 1263
  • [3] Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin
    Nguyen, Nghia H.
    McCormack, Shelley A.
    Vutien, Philip
    Yee, Brittany E.
    Devaki, Pardha
    Jencks, David
    Nguyen, Mindie H.
    INTERVIROLOGY, 2015, 58 (01) : 27 - 34
  • [4] Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
    Fardin Dolatimehr
    Hamidreza Karimi-Sari
    Mohammad Saeid Rezaee-Zavareh
    Seyed Moayed Alavian
    Bita Behnava
    Mohammad Gholami-Fesharaki
    Heidar Sharafi
    DARU Journal of Pharmaceutical Sciences, 25
  • [5] Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks
    Nghia H. Nguyen
    Shelley A. McCormack
    Brittany E. Yee
    Pardha Devaki
    David Jencks
    David T. Chao
    Mindie H. Nguyen
    Hepatology International, 2014, 8 : 540 - 549
  • [6] Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks
    Nguyen, Nghia H.
    McCormack, Shelley A.
    Yee, Brittany E.
    Devaki, Pardha
    Jencks, David
    Chao, David T.
    Nguyen, Mindie H.
    HEPATOLOGY INTERNATIONAL, 2014, 8 (04) : 540 - 549
  • [7] Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
    Dolatimehr, Fardin
    Karimi-Sari, Hamidreza
    Rezaee-Zavareh, Mohammad Saeid
    Alavian, Seyed Moayed
    Behnava, Bita
    Gholami-Fesharaki, Mohammad
    Sharafi, Heidar
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 25
  • [8] Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin
    Yee, Brittany E.
    Nguyen, Nghia H.
    Zhang, Bing
    Vutien, Philip
    Wong, Carrie R.
    Lutchman, Glen A.
    Nguyen, Mindie H.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (11) : 1189 - 1201
  • [9] Sofosbuvir and Ribavirin with or Without Pegylated-Interferon in Hepatitis C Virus Genotype-2 or -3 Infections: A Systematic Review and Meta-Analysis
    Bayatpoor, Mohammad Ehsan
    Khosravi, Mohammad Hossein
    Sharafi, Heidar
    Rezaee-Zavareh, Mohammad Saeid
    Behnava, Bita
    Alavian, Seyed Moayed
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2019, 14 (01):
  • [10] Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus-Coinfected Patients With Compensated Cirrhosis
    Mira, Jose A.
    Rivero-Juarez, Antonio
    Lopez-Cortes, Luis F.
    Giron-Gonzalez, Jose A.
    Tellez, Francisco
    de los Santos-Gil, Ignacio
    Macias, Juan
    Merino, Dolores
    Marquez, Manuel
    Rios-Villegas, Maria J.
    Gea, Isabel
    Merchante, Nicolas
    Rivero, Antonio
    Torres-Cornejo, Almudena
    Pineda, Juan A.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (11) : 1646 - 1653
12345